Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 60, Issue 1

Refractory bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia No Access

Abstract

Bacillary angiomatosis is a well-recognized infection with cutaneous and systemic manifestations caused by or and occurs in immunocompromised patients. We report a case of bacillary angiomatosis following fludarabine-based chemotherapy for chronic lymphocytic leukaemia that was refractory to standard treatment and was complicated by lymphadenopathy and osteomyelitis.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): CLL, chronic lymphocytic leukaemia
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.015867-0
2011-01-01
2025-04-24
Loading full text...

Full text loading...

References

  1. Alsmark C. M., Frank A. C., Karlberg E. O., Legault B.-A., Ardell D. H., Canback B., Eriksson A.-S., Naslund A. K., Handley S. A. other authors 2004; The louse-borne human pathogen Bartonella quintana is a genomic derivative of the zoonotic agent Bartonella henselae . Proc Natl Acad Sci U S A 101:9716–9721 [CrossRef]
     [Google Scholar]
  2. Anaissie E. J., Kontoyiannis D. P., O'Brien S., Kantarjian H., Robertson L., Lerner S., Keating M. J. 1998; Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 129:559–566 [CrossRef]
     [Google Scholar]
  3. Anderson B., Sims K., Regnery R., Robinson L., Schmidt M. J., Goral S., Hager C., Edwards K. 1994; Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR. J Clin Microbiol 32:942–948
     [Google Scholar]
  4. Bergmann L., Fenchel K., Jahn B., Mitrou P. S., Hoelzer D. 1993; Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia. Ann Oncol 4:371–375
     [Google Scholar]
  5. Bonatti H., Mendez J., Guerrero I., Krishna M., Ananda-Michel J., Yao J., Steers J. L., Hellinger W., Dickson R. C., Alvarez S. 2006; Disseminated Bartonella infection following liver transplantation. Transpl Int 19:683–687 [CrossRef]
     [Google Scholar]
  6. Brouqui P., Lascola B., Roux V., Raoult D. 1999; Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med 340:184–189 [CrossRef]
     [Google Scholar]
  7. Chang C.-C., Chomel B. B., Kasten R. W., Tappero J. W., Sanchez M. A., Koehler J. E. 2002; Molecular epidemiology of Bartonella henselae infection in human immunodeficiency virus-infected patients and their cat contacts, using pulsed-field gel electrophoresis and genotyping. J Infect Dis 186:1733–1739 [CrossRef]
     [Google Scholar]
  8. Chapel H. M., Bunch C. 1987; Mechanisms of infection in chronic lymphocytic leukemia. Semin Hematol 24:291–296
     [Google Scholar]
  9. Chomel B. B., Boulouis H.-J., Maruyama S., Breitschwerdt E. B. 2006; Bartonella spp. in pets and effect on human health. Emerg Infect Dis 12:389–394 [CrossRef]
     [Google Scholar]
  10. Dörbecker C., Sander A., Oberle K., Schülin-Casonato T. 2006; In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of Etest and agar dilution. J Antimicrob Chemother 58:784–788 [CrossRef]
     [Google Scholar]
  11. Fabbi M., De Giuli L., Tranquillo M., Bragoni R., Casiraghi M., Genchi C. 2004; Prevalence of Bartonella henselae in Italian stray cats: evaluation of serology to assess the risk of transmission of Bartonella to humans. J Clin Microbiol 42:264–268 [CrossRef]
     [Google Scholar]
  12. Foucault C., Raoult D., Brouqui P. 2003; Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia. Antimicrob Agents Chemother 47:2204–2207 [CrossRef]
     [Google Scholar]
  13. Foucault C., Brouqui P., Raoult D. 2006; Bartonella quintana characteristics and clinical management. Emerg Infect Dis 12:217–223 [CrossRef]
     [Google Scholar]
  14. Gasquet S., Maurin M., Brouqui P., Lepidi H., Raoult D. 1998; Bacillary angiomatosis in immunocompromised patients. AIDS 12:1793–1803 [CrossRef]
     [Google Scholar]
  15. Holmes N. E., Hodgkinson M., Dendle C., Korman T. M. 2008; Report of oral clarithromycin desensitization. Br J Clin Pharmacol 66:323–324 [CrossRef]
     [Google Scholar]
  16. Koehler J. E., Tappero J. W. 1993; Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin Infect Dis 17:612–624 [CrossRef]
     [Google Scholar]
  17. Koehler J. E., Sanchez M. A., Garrido C. S., Whitfeld M. J., Chen F. M., Berger T. G., Rodriguez-Barradas M. C., Leboit P. E., Tappero J. W. 1997; Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med 337:1876–1883 [CrossRef]
     [Google Scholar]
  18. La Scola B., Raoult D. 1996; Serological cross-reactions between Bartonella quintana , Bartonella henselae , and Coxiella burnetii . J Clin Microbiol 34:2270–2274
     [Google Scholar]
  19. La Scola B., Raoult D. 1999; Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience; (1993 to 1998 J Clin Microbiol 37:1899–1905
     [Google Scholar]
  20. Mantadakis E., Spanaki A.-M., Psaroulaki A., Fitrolaki D., Minadakis G., Michaeloudi E., Tselentis Y., Briassoulis G. 2007; Encephalopathy complicated by Guillain-Barre syndrome and hydrocephalus and associated with acute Bartonella quintana infection. Pediatr Infect Dis J 26:860–862 [CrossRef]
     [Google Scholar]
  21. Margileth A. M. 2000; Recent advances in diagnosis and treatment of cat scratch disease. Curr Infect Dis Rep 2:141–146 [CrossRef]
     [Google Scholar]
  22. Maurin M., Raoult D. 1996; Bartonella ( Rochalimaea ) quintana infections. Clin Microbiol Rev 9:273–292
     [Google Scholar]
  23. Maurin M., Raoult D. 1998; Bartonella infections: diagnostic and management issues. Curr Opin Infect Dis 11:189–193 [CrossRef]
     [Google Scholar]
  24. Maurin M., Birtles R., Raoult D. 1997; Current knowledge of Bartonella species. Eur J Clin Microbiol Infect Dis 16:487–506 [CrossRef]
     [Google Scholar]
  25. Meghari S., Rolain J.-M., Grau G. E., Platt E., Barrassi L., Mege J.-L., Raoult D. 2006; Antiangiogenic effect of erythromycin: an in vitro model of Bartonella quintana infection. J Infect Dis 193:380–386 [CrossRef]
     [Google Scholar]
  26. Milde P., Brunner M., Borchard F., Sudhoff T., Burk M., Zumdick M., Goerz G., Ruzicka T. 1995; Cutaneous bacillary angiomatosis in a patient with chronic lymphocytic leukemia. Arch Dermatol 131:933–936 [CrossRef]
     [Google Scholar]
  27. Mohle-Boetani J. C., Koehler J. E., Berger T. G., Leboit P. E., Kemper C. A., Reingold A. L., Plikaytis B. D., Wenger J. D., Tappero J. W. 1996; Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study. Clin Infect Dis 22:794–800 [CrossRef]
     [Google Scholar]
  28. O'Brien S., Kantarjian H., Beran M., Smith T., Koller C., Estey E., Robertson L. E., Lerner S., Keating M. 1993; Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood 82:1695–1700
     [Google Scholar]
  29. Petersen K., Earhart K., Wallace M. 2008; Bacillary angiomatosis in a patient with chronic lymphocytic leukemia. Infection 36:480–484 [CrossRef]
     [Google Scholar]
  30. Raoult D., Fournier P. E., Vandenesch F., Mainardi J. L., Eykyn S. J., Nash J., James E., Benoit-Lemercier C., Marrie T. J. 2003; Outcome and treatment of Bartonella endocarditis. Arch Intern Med 163:226–230 [CrossRef]
     [Google Scholar]
  31. Rathbone P., Graves S., Miller D., Odorico D., Jones S., Hellyar A., Sinickas V., Grigg A. 1996; Bartonella ( Rochalimaea ) quintana causing fever and bacteremia in an immunocompromised patient with non-Hodgkin's lymphoma. Pathology 28:80–83 [CrossRef]
     [Google Scholar]
  32. Rolain J. M., Maurin M., Raoult D. 2000; Bactericidal effect of antibiotics on Bartonella and Brucella spp.: clinical implications. J Antimicrob Chemother 46:811–814 [CrossRef]
     [Google Scholar]
  33. Rolain J. M., Brouqui P., Koehler J. E., Maguina C., Dolan M. J., Raoult D. 2004; Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 48:1921–1933 [CrossRef]
     [Google Scholar]
  34. Sander A., Posselt M., Oberle K., Bredt W. 1998; Seroprevalence of antibodies to Bartonella henselae in patients with cat scratch disease and in healthy controls: evaluation and comparison of two commercial serological tests. Clin Diagn Lab Immunol 5:486–490
     [Google Scholar]
  35. Schwartz R. A., Nychay S. G., Janniger C. K., Lambert W. C. 1997; Bacillary angiomatosis: presentation of six patients, some with unusual features. Br J Dermatol 136:60–65 [CrossRef]
     [Google Scholar]
  36. Tappero J. W., Koehler J. E., Berger T. G., Cockerell C. J., Lee T. H., Busch M. P., Stites D. P., Mohle-Boetani J., Reingold A. L., Leboit P. E. 1993; Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med 118:363–365 [CrossRef]
     [Google Scholar]
  37. Tea A., Alexiou-Daniel S., Arvanitidou M., Diza E., Antoniadis A. 2003; Occurrence of Bartonella henselae and Bartonella quintana in a healthy Greek population. Am J Trop Med Hyg 68:554–556
     [Google Scholar]
  38. Török L., Virágh S. Z., Borka I., Tápai M. 1994; Bacillary angiomatosis in a patient with lymphocytic leukaemia. Br J Dermatol 130:665–668 [CrossRef]
     [Google Scholar]
  39. Vermeulen M. J., Herremans M., Verbakel H., Bergmans A. M. C., Roord J. J., Van Dijken P. J., Peeters M. F. 2007; Serological testing for Bartonella henselae infections in The Netherlands: clinical evaluation of immunofluorescence assay and ELISA. Clin Microbiol Infect 13:627–634 [CrossRef]
     [Google Scholar]
  40. Wijermans P. W., Gerrits W. B., Haak H. L. 1993; Severe immunodeficiency in patients treated with fludarabine monophosphate. Eur J Haematol 50:292–296
     [Google Scholar]
  41. Woolley M. W., Gordon D. L., Wetherall B. L. 2007; Analysis of the first Australian strains of Bartonella quintana reveals unique genotypes. J Clin Microbiol 45:2040–2043 [CrossRef]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.015867-0
Loading
Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia
J. Med. Microbiol. 60, 142 (2011); https://doi.org/10.1099/jmm.0.015867-0
/content/journal/jmm/10.1099/jmm.0.015867-0
/content/journal/jmm/10.1099/jmm.0.015867-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error